Radiopharmaceutical producer International Isotopes this month signed a technology development deal with a Texas university that the company hopes will lead to a nuclear medicine camera with up to four times the resolution of systems on the market.
Radiopharmaceutical producer International Isotopes this month signed a technology development deal with a Texas university that the company hopes will lead to a nuclear medicine camera with up to four times the resolution of systems on the market. International Isotopes of Denton, TX, is combining its nuclear medicine patent portfolio with that of University of Texas Southwestern Medical Center in Dallas to develop the camera, according to Carl Seidel, president and CEO.
The system to be developed could be either a PET or SPECT camera, or a combination of the two technologies, Seidel said. International Isotopes believes that the camera is capable of spatial resolution in the 0.5-mm to 1.3-mm range, which would be a fourfold improvement on conventional gamma cameras.
The camera achieves such high specifications through noise reduction and better detectors, Seidel said. The system's detectors will be based on digital technology, although the company declined to specify whether it will be a solid-state unit. International Isotopes is in discussions with other vendors regarding a manufacturing agreement for the system.
In other International Isotopes news, the company last month raised $10 million through a private stock placement. The funds will be used to complete installation of the cyclotron and linear accelerator that International Isotopes will use to produce radioisotopes.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.